CYTOMETRY PART B-CLINICAL CYTOMETRY, published by Wiley, is a premier journal dedicated to advancing the field of cytometry with a specific focus on its clinical applications. With an impact factor reflective of its influential role in the scientific community, this journal serves as an essential resource for researchers, professionals, and students keen on exploring the latest developments in pathology, histology, and cell biology. The journal holds impressive rankings—Q1 in Pathology and Forensic Medicine and Q2 in Histology—illustrating its critical standing within the academic landscape. Covering a wide array of topics from clinical techniques to innovative applications in cytometry, it aims to disseminate high-quality research findings that contribute to enhanced diagnostic and therapeutic strategies. As an Open Access journal, it ensures that its valuable content reaches a broader audience, facilitating knowledge-sharing and fostering collaborations across interdisciplinary fields. Since its inception in 2002, CYTOMETRY PART B continues to shape the future of clinical cytometry, making significant contributions to both academia and clinical practice.

The Annals of Clinical Biochemistry, published by SAGE Publications Inc, is a prestigious journal that has been pivotal in advancing the field of clinical biochemistry since its inception. With an ISSN of 0004-5632 and an E-ISSN of 1758-1001, this journal provides a platform for high-quality, peer-reviewed research articles, reviews, and case studies that cover a wide range of topics, including biochemical analysis, diagnostic methodologies, and the latest advancements in clinical practices. As a recognized leader in the field, it holds a Q2 ranking in both Clinical Biochemistry and Miscellaneous Medicine categories, showcasing its contribution to the evolving landscape of medical science. The journal’s impact is further underscored by its strategic emphasis on fostering collaboration between researchers and healthcare professionals. Although it does not provide Open Access options, the accessible subscription model ensures that vital research remains within reach of academic and clinical institutions. The Annals of Clinical Biochemistry aims to promote the understanding and application of biochemical techniques in clinical settings, ensuring it remains an essential resource for researchers, professionals, and students alike.

International Cardiovascular Research Journal, published by Shiraz University Medical Sciences, serves as a vital platform for the dissemination of cutting-edge research in the field of cardiology and cardiovascular medicine. Since its inception in 2011, this journal has continuously devoted itself to promoting the highest quality of scholarly communication, helping to bridge the gap between laboratory findings and clinical application. With an ISSN of 2251-9130 and an E-ISSN of 2251-9149, it is indexed in prominent databases, contributing to its visibility and accessibility to a global audience. Although currently classified in the Q4 quartile in the 2023 rankings, the journal is committed to enhancing its impact factor and academic stature. It aims to facilitate open access for all published articles, although specific details on access options are pending. Through its rigorous peer-review process and diverse scope—which encapsulates advancements, clinical studies, and innovative therapeutic strategies—this journal fosters academic collaboration in the realm of cardiovascular health, making it an invaluable resource for researchers, practitioners, and students alike.

The International Journal of Laboratory Hematology, published by WILEY, serves as a vital resource in the field of hematology, delivering high-quality research findings and innovations within laboratory practices since its inception in 2007. This journal, accessible under Open Access options, showcases cutting-edge studies that span critical aspects of biochemistry and clinical laboratory methodologies. With a notable impact factor reflected in its Q2 and Q3 rankings across various categories—such as Biochemistry (medical) and Hematology—this journal stands out within the Scopus rankings, positioning itself within the 60th and 59th percentiles of its respective fields. Situated in the United Kingdom, the journal's objectives lie in disseminating pivotal research that enhances our understanding of hematological disorders and laboratory techniques, making it an essential tool for researchers, professionals, and students alike who are committed to advancing the science of laboratory hematology and its applications.

ANNALES DE BIOLOGIE CLINIQUE is a prominent French journal dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Immunology, and Microbiology. Published by JOHN LIBBEY EUROTEXT LTD, this journal has been a pivotal resource since its inception in 1945, offering a rich archive of original research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and clinical applications. Despite its ranking in the Q4 quartile within several scientific categories according to the 2023 Scopus rankings—positioning it at #395/636 in General Medicine and #198/221 in General Biochemistry—ANNALES DE BIOLOGIE CLINIQUE serves as a vital platform for emerging researchers and seasoned professionals alike, fostering collaboration and innovation in these vital areas of health science. As an essential tool for researchers and scholars, the journal does not currently provide open access; however, it continuously strives to enhance its impact and visibility in the scientific community through rigorous peer-reviewed content and educational contributions.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

Bioanalysis is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of analytical and clinical biochemistry. Established in 2009, this journal has become a pivotal platform for high-quality, peer-reviewed research that explores innovative techniques in bioanalytical sciences, appealing to researchers, professionals, and students alike. With an impressive impact factor and ranked in the Q2 and Q3 quartiles across various categories, including Clinical Biochemistry and Pharmacology, Toxicology and Pharmaceutics, Bioanalysis serves as an essential resource for the latest developments in the interdisciplinary aspects of medicine and laboratory technology. While it does not currently offer open access, the journal is indexed in Scopus, ensuring visibility and accessibility to a global audience. The publication's commitment to enhancing knowledge in this vital area of research underscores its significance in fostering advancements that can lead to improved healthcare outcomes.

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.